stock

Why Specialty Pharmacies Struggle to Scale Patient Access Operations

stock_C
stock_b
stock_a
Why Specialty Pharmacies Struggle to Scale Patient Access

Share

Specialty pharmacies often believe growth challenges begin when referral volumes outpace staffing capacity. The assumption seems logical. More referrals should require more people, more resources, and more operational support. Yet many organizations discover a frustrating reality. Referral volumes continue to rise, but therapy starts fail to keep pace.

This disconnect highlights one of the most overlooked challenges in specialty pharmacy patient access. Most organizations assume they have a staffing problem when they actually have a patient conversion problem. The true constraint is not the number of referrals entering the system. The constraint is how efficiently those referrals move through specialty pharmacy patient access operations and become successful therapy starts.

As specialty medications continue to represent a growing share of healthcare spending, pharmacy leaders face increasing pressure to improve operational scalability. Patients expect faster access to treatment. Providers expect timely communication. Payers continue to add administrative complexity. Consequently, specialty pharmacy operations must evolve beyond traditional approaches to patient access management.

The organizations winning today are not necessarily processing more referrals. Instead, they are reducing friction across the therapy initiation process. They understand that specialty pharmacy patient access is not an administrative function. It is a growth engine.

Executive Framework

The Hidden Patient Access Funnel

Every stage of patient access introduces operational friction. As referrals move through the funnel, delays, documentation issues, and communication breakdowns reduce therapy start conversion rates.

Referral Intake
Missing Documentation

Insurance Verification
Eligibility Discrepancies

Benefits Investigation
Coverage Delays

Prior Authorization
Payer Bottlenecks

Patient Activation
Lost Communication

Therapy Initiation
Delayed Revenue Realization
Key Takeaway
Most specialty pharmacies do not struggle because of referral volume. They struggle because conversion losses occur at every stage of the patient access funnel. Improving therapy starts requires reducing friction across verification, benefits investigation, authorization, and patient engagement workflows.

The Specialty Pharmacy Growth Paradox

Many specialty pharmacies invest heavily in technology, staffing, and workflow improvements. However, despite these investments, specialty pharmacy patient access challenges often persist. The reason is simple. Most organizations focus on increasing activity instead of improving conversion.

More referrals do not automatically create more therapy starts. Every patient must successfully navigate referral intake, insurance verification services, benefits verification services, prior authorization support, pharmacy patient onboarding, and therapy initiation support before treatment begins. A delay at any stage creates a ripple effect throughout the patient journey.

Research published in the Journal of Managed Care & Specialty Pharmacy found that delays in access-related processes continue to affect treatment timelines and patient outcomes.

H3: More Referrals Do Not Guarantee More Therapy Starts

Consider two specialty pharmacies receiving identical referral volumes.

The first pharmacy measures productivity through completed tasks. Teams focus on processing referrals, handling calls, and managing documentation.

The second pharmacy measures referral-to-therapy-start conversion. Every workflow is designed to reduce friction and accelerate patient movement toward treatment.

Both organizations may appear equally busy. Yet one consistently delivers faster therapy starts, stronger patient engagement, and higher operational efficiency.

The difference is not effort. The difference is design.

Operational Growth Analysis

Referral Growth vs Therapy Start Growth

Workflow fragmentation often causes therapy start growth to lag behind referral growth, creating a widening conversion gap across patient access operations.

1st Year
1,000 Referrals | 850 Therapy Starts

2nd Year
1,300 Referrals | 1,020 Therapy Starts

3rd Year
1,700 Referrals | 1,220 Therapy Starts

4th Year
2,200 Referrals | 1,450 Therapy Starts

Referrals
Therapy Starts

Executive Insight
The organizations that scale patient access successfully are not processing more work. They are eliminating the friction that prevents patients from reaching therapy.

The Five Conversion Points That Determine Patient Access Performance

High-performing specialty pharmacies understand that patient access bottlenecks in specialty pharmacy rarely originate from a single issue. Instead, they emerge across multiple conversion points.

Referral Intake

The patient journey begins with referral intake. Missing documentation, incomplete demographic information, and inconsistent provider communication often create the first delay. At scale, even small intake inefficiencies can significantly increase turnaround times.

Insurance Verification and Benefits Investigation

Insurance verification services and benefits investigation activities represent one of the most resource-intensive phases of specialty pharmacy onboarding. Coverage discrepancies, payer-specific requirements, and benefit limitations frequently create delays that extend treatment timelines. Organizations seeking to reduce benefits verification delays can learn more here:

Prior Authorization Workflow

The prior authorization workflow remains one of the largest administrative barriers to timely treatment. Many specialty pharmacies still rely on manual coordination between providers, payers, and patients. As referral volumes increase, these processes become increasingly difficult to manage efficiently.

Patient Activation

Patients cannot begin therapy if communication breaks down. Many organizations underestimate how often therapy initiation delays occur simply because patients are difficult to reach or uncertain about next steps. Successful patient engagement strategies focus on proactive communication rather than reactive outreach.

Therapy Initiation

Every previous stage exists to support one outcome: therapy initiation. When organizations fail to optimize earlier conversion points, therapy starts suffer. Consequently, patient retention, provider satisfaction, and revenue performance decline.

Why Specialty Pharmacy Staffing Challenges Are Often Misdiagnosed

When specialty pharmacy operations begin to struggle, leaders frequently assume additional staffing is the solution. While staffing investments can provide short-term relief, they rarely solve the root problem. Most specialty pharmacy staffing challenges are symptoms of workflow inefficiencies rather than true capacity limitations.

Activity Metrics vs Outcome Metrics

Many organizations continue measuring operational success through activity-based metrics.

Common examples include:

  • Referrals processed
  • Calls completed
  • Cases handled

These metrics provide useful operational information. However, they fail to answer the most important question.

Did the patient start therapy?

Organizations focused on specialty pharmacy growth strategies increasingly track:

  • Referral-to-therapy-start conversion
  • Days to therapy initiation
  • Patient retention
  • Patient engagement
  • Therapy start rates

These metrics provide a more accurate view of specialty pharmacy operational efficiency.

As one healthcare executive famously observed:

What gets measured gets managed.

The challenge is ensuring the right outcomes are being measured.

The Specialty Pharmacies Winning the Race to Therapy Start

The most successful specialty pharmacies do not simply add more staff when demand increases. Instead, they redesign how work flows through the organization.

Operational excellence begins with standardized workflows, stronger workforce management, and fewer process handoffs. Enhanced visibility across the patient journey allows leadership teams to identify inefficiencies, improve coordination, and support faster therapy initiation.

Most importantly, they recognize that patient access services for specialty pharmacy directly influence both clinical outcomes and financial performance.

Organizations that excel in this area often integrate benefits verification services, insurance verification services, prior authorization support, patient onboarding services, and therapy initiation support into a coordinated operating model.

For additional insight into the importance of early-stage onboarding, read Ameridial’s analysis of the specialty pharmacy onboarding process:

Operating Model Comparison

Traditional vs Scalable Patient Access Model

High-performing specialty pharmacies scale through workflow optimization and conversion efficiency, not simply through increased staffing.

Traditional Model
Scalable Model

Measures activity
Measures therapy starts

Adds staff to solve delays
Removes workflow friction

Operates in silos
Operates as one patient journey

Reactive communication
Proactive patient engagement

Limited visibility
End-to-end workflow visibility

Focuses on tasks
Focuses on conversion
Strategic Insight
Specialty medications account for more than half of total U.S. drug spending despite serving a relatively small percentage of patients. As specialty drug utilization grows, efficient patient access operations become increasingly important for both patient outcomes and organizational growth. – IQVIA Institute Specialty Medicines Report

The Future of Specialty Pharmacy Growth Will Be Won Before Dispensing Begins

The future of specialty pharmacy growth will not be determined by who can fill the most prescriptions. It will be determined by who can move patients through the therapy initiation process with the least friction.

Every successful therapy start depends on efficient referral intake, accurate insurance coverage verification, streamlined benefits investigation, proactive patient engagement, and effective prior authorization workflows. When these functions operate independently, delays become inevitable. When they operate as a unified system, organizations achieve greater operational scalability, stronger patient outcomes, and improved financial performance.

The specialty pharmacies that thrive in the years ahead will not be those with the largest teams. They will be those with the most efficient patient access operating models.

Ready to Improve Specialty Pharmacy Patient Access Performance?

If referral volumes are increasing but therapy starts are not keeping pace, the problem may not be staffing levels or dispensing capacity. It may be the design of your patient access operation.

Ameridial helps specialty pharmacies optimize specialty pharmacy patient access through comprehensive pharmacy support services, including benefits verification services, insurance verification services, prior authorization support, patient onboarding services, therapy initiation support, and patient engagement solutions. Connect with our team to identify workflow bottlenecks, accelerate therapy starts, reduce revenue leakage, and build a scalable patient access strategy that supports long-term growth.

Joanna Walter
Joanna Walter
LinkedIn

Vice President – Healthcare, Ameridial

Drives the organization’s healthcare vertical, shaping strategy, client partnerships, and delivery across member and patient engagement services. With over 20 years of experience in healthcare operations, she blends operational excellence with a people-first mindset. Joanna is passionate about building strong client relationships and helping healthcare organizations elevate service quality, improve member satisfaction, and navigate complex, regulated environments with confidence.

Schedule Your Free Healthcare CX Consultation Today

    Healthcare Insights

    Discover healthcare insights worth reading—designed to inform, inspire,
    & transform how you connect payers, providers, and patients.